← Back to patent-cliff list
CAS 116-26-7
2,6,6-trimethylcyclohexa-1,3-dienecarbaldehyde
Codes: ALIT-021
Application context (from source-drug indications)
Kaposi's sarcomaAlitretinoinHIV infectionAlitretinoinPsoriasisAlitretinoinEczemaAlitretinoin口腔扁平苔藓AlitretinoinBreast cancerAlitretinoin
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Alitretinoin | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(2E,4E,6Z,8E)-ethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoate→ethyl (E)-4-(diethoxyphosphoryl)-3-methylbut-2-enoate→2,6,6-trimethylcyclohex-1-enecarbaldehyde→2,6,6-trimethylcyclohexa-1,3-dienecarbaldehyde→ethyl 3-methylbut-2-enoate→4-methyl-6-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)-5,6-dihydro-2H-pyran-2-one→(2Z,4E)-3-methyl-5-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)penta-2,4-dienal→(2E,4E,6Z,8E)-ethyl 3,7-dimethyl-9-(2,6,6-trimethylcyclohexa-1,3-dien-1-yl)nona-2,4,6,8-tetraenoate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.